Department of Ophthalmology, Osaka University Medical School, Osaka, Japan.
Jpn J Ophthalmol. 2012 Nov;56(6):584-8. doi: 10.1007/s10384-012-0172-1. Epub 2012 Sep 7.
Patients with Stargardt's disease usually have a poor visual prognosis. However, in our clinical practice we have observed some patients with dark-red foveal pigmentation (sparing) who had good best corrected visual acuity (BCVA) despite the presence of a late-stage disease. The purpose of this study was to investigate the BCVA outcomes in Japanese patients with Stargardt's disease with foveal sparing.
Eighteen consecutive patients (36 eyes) with Stargardt's disease underwent ophthalmoscopy, fluorescein angiography, fundus autofluorescence imaging, and near-infrared fundus autofluorescence (NIA) imaging. The patients were divided into two groups based on the presence or absence of foveal sparing. The presence of foveal sparing was determined based on ophthalmoscopy and NIA imaging results. The association between foveal sparing and BCVA was assessed statistically by Students' t test.
Of the 36 eyes, ten (27.8 %) had dark-red foveal sparing. The mean BCVA of the group with sparing was 0.16 ± 0.31, expressed in logarithm of the minimum angle of resolution (logMAR) units, and that of the group without sparing was 1.03 ± 0.39 logMAR units, which is a significant difference (p = 0.0000002507).
A subgroup of Japanese patients with late-stage Stargardt's disease and dark-red foveal sparing maintained a relatively good BCVA. The pigmentation was clearly observed using NIA and proved useful for assessing the BCVA prognosis.
斯特格病患者的视力预后通常较差。然而,在我们的临床实践中,我们观察到一些具有暗红色中心凹色素沉着(保留)的患者尽管存在晚期疾病,但最佳矫正视力(BCVA)仍然很好。本研究的目的是探讨具有中心凹保留的日本斯特格病患者的 BCVA 结局。
18 例(36 只眼)连续的斯特格病患者接受了眼底镜检查、荧光素血管造影、眼底自发荧光成像和近红外眼底自发荧光(NIA)成像。根据是否存在中心凹保留,将患者分为两组。根据眼底镜和 NIA 成像结果确定中心凹保留的存在。采用学生 t 检验评估中心凹保留与 BCVA 之间的相关性。
在 36 只眼中,有 10 只(27.8%)眼存在暗红色中心凹保留。保留组的平均 BCVA 为 0.16 ± 0.31,以最小分辨角对数(logMAR)单位表示,无保留组的平均 BCVA 为 1.03 ± 0.39 logMAR 单位,差异有统计学意义(p=0.0000002507)。
日本晚期斯特格病患者中有一个亚组存在暗红色中心凹保留,保持了相对较好的 BCVA。NIA 可清晰观察到色素沉着,有助于评估 BCVA 预后。